Additionally, due to the significant overlap in the clinical features of GPA and MPA, CHCC2012 recommended adding a prefix to the clinical phenotype of patients with established AAV (classified as PR3-ANCA disease and MPO-ANCA disease based on ANCA specificity) (26). Here, PRTN3 is linked to anti-neutrophil cytoplasmic antibody-associated vasculitis.